These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26067809)

  • 21. Telomerase activity in ductal carcinoma in situ and invasive breast cancer.
    Umbricht CB; Sherman ME; Dome J; Carey LA; Marks J; Kim N; Sukumar S
    Oncogene; 1999 Jun; 18(22):3407-14. PubMed ID: 10362362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.
    Speyer CL; Nassar MA; Hachem AH; Bukhsh MA; Jafry WS; Khansa RM; Gorski DH
    Breast Cancer Res Treat; 2016 Jun; 157(2):217-228. PubMed ID: 27146584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
    Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
    Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new preclinical 3-dimensional agarose colony formation assay.
    Kajiwara Y; Panchabhai S; Levin VA
    Technol Cancer Res Treat; 2008 Aug; 7(4):329-34. PubMed ID: 18642971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation.
    Zuo J; Yu Y; Zhu M; Jing W; Yu M; Chai H; Liang C; Tu J
    Cancer Biomark; 2018 Feb; 21(2):383-392. PubMed ID: 29103027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
    Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
    BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying chemopreventive agents for obesity-associated cancers using an efficient, 3D high-throughput transformation assay.
    Benham V; Bullard B; Dexheimer TS; Bernard MP; Neubig RR; Liby KT; Bernard JJ
    Sci Rep; 2019 Jul; 9(1):10278. PubMed ID: 31311976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of curcumin effects on breast adenocarcinoma 2D and 3D cell cultures.
    Abuelba H; Cotrutz CE; Stoica BA; Stoica L; Olinici D; Petreuş T
    Rom J Morphol Embryol; 2015; 56(1):71-6. PubMed ID: 25826489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting breast cancer stem cells by novel HDAC3-selective inhibitors.
    Hsieh HY; Chuang HC; Shen FH; Detroja K; Hsin LW; Chen CS
    Eur J Med Chem; 2017 Nov; 140():42-51. PubMed ID: 28923385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings.
    Jang B; Kim HW; Kim JS; Kim WS; Lee BR; Kim S; Kim H; Han SJ; Ha SJ; Shin SJ
    J Leukoc Biol; 2015 Feb; 97(2):351-62. PubMed ID: 25420918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial.
    Bundred NJ; Cramer A; Morris J; Renshaw L; Cheung KL; Flint P; Johnson R; Young O; Landberg G; Grassby S; Turner L; Baildam A; Barr L; Dixon JM
    Clin Cancer Res; 2010 Mar; 16(5):1605-12. PubMed ID: 20179229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular markers and therapeutic targets in ductal carcinoma in situ.
    Boland GP; Knox WF; Bundred NJ
    Microsc Res Tech; 2002 Oct; 59(1):3-11. PubMed ID: 12242692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
    Hou ZJ; Luo X; Zhang W; Peng F; Cui B; Wu SJ; Zheng FM; Xu J; Xu LZ; Long ZJ; Wang XT; Li GH; Wan XY; Yang YL; Liu Q
    Oncotarget; 2015 Mar; 6(8):6326-40. PubMed ID: 25811972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.
    Gernapudi R; Yao Y; Zhang Y; Wolfson B; Roy S; Duru N; Eades G; Yang P; Zhou Q
    Breast Cancer Res Treat; 2015 Apr; 150(3):685-95. PubMed ID: 25783182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression.
    Salvador MA; Wicinski J; Cabaud O; Toiron Y; Finetti P; Josselin E; Lelièvre H; Kraus-Berthier L; Depil S; Bertucci F; Collette Y; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Clin Cancer Res; 2013 Dec; 19(23):6520-31. PubMed ID: 24141629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
    Foudah AI; Sallam AA; Akl MR; El Sayed KA
    Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells.
    Lui A; New J; Ogony J; Thomas S; Lewis-Wambi J
    BMC Cancer; 2016 Jul; 16():487. PubMed ID: 27421652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.